Bioresorbable Scaffolds as a Preferred Treatment for Ruptured Plaques and Younger ACS Patients: Is It Still a Possibility?

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker's Bureau - Abbott; AstraZenca; Boston Scientific Corporation; Biotronik; Terumo Medical Corporation; Boehringer Ingelheim; Pfizer</li><li>Grant Support/Research Contract - Meril</li></ul>